Document is current
Any future updates will be listed below
-
Authors
Cairat, Manon
Olesen, Morten
Olivier, Elea
Pottegård, Anton
Hicks, Blánaid
-
Funding
Funding for this research was provided by:
Postdoctoral fellowship from the DOUBS - Montbéliard and JURA committees of the French League Against Cancer
UICC Yamagiwa-Yoshida Memorial International Cancer Study Grant
- License Information
-
More Information
Article History
Received: 18 November 2024
Accepted: 16 June 2025
First Online: 23 June 2025
Declarations
:
: No ethical approval was required for this study. The study was registered in the University of Southern Denmark’s research repository, and necessary permissions for data extraction were obtained from Statistics Denmark.
: Not applicable.
: Anton Pottegård reports participation in research projects funded by Alcon, Almirall, Astellas, AstraZeneca, Boehringer-Ingelheim, Novo Nordisk, Servier and LEO Pharma (all regulator-mandated phase IV-studies), and an unrestricted research grant from Novo Nordisk, all with funds paid to the institution where he was employed (no personal fees) and with no relation to the work reported in this article. All remaining authors declare have no competing interests to declare.
